BioLineRx Ltd.
BLRX
$3.61
-$0.24-6.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.82M | -3.40M | -9.22M | -19.92M | -30.12M |
| Total Depreciation and Amortization | 2.96M | 3.26M | 3.99M | 2.86M | 2.24M |
| Total Amortization of Deferred Charges | 1.44M | 2.09M | 1.38M | 701.00K | 701.00K |
| Total Other Non-Cash Items | -15.30M | -22.74M | -18.21M | -7.21M | -1.07M |
| Change in Net Operating Assets | -2.49M | -11.56M | -21.82M | -6.70M | -2.10M |
| Cash from Operations | -21.20M | -32.36M | -43.87M | -30.27M | -30.35M |
| Capital Expenditure | 6.00K | -21.00K | -53.00K | -75.00K | -76.00K |
| Sale of Property, Plant, and Equipment | 11.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.43M | 4.53M | 29.43M | -2.10M | -8.18M |
| Cash from Investing | 9.45M | 4.51M | 29.37M | -2.18M | -8.26M |
| Total Debt Issued | 0.00 | 19.22M | 19.22M | 19.22M | 19.22M |
| Total Debt Repaid | -15.64M | -15.30M | -14.94M | -3.70M | -3.61M |
| Issuance of Common Stock | 24.55M | 27.26M | 16.56M | 18.17M | 22.61M |
| Repurchase of Common Stock | -180.00K | -180.00K | -180.00K | -180.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8.73M | 31.00M | 20.66M | 33.51M | 38.22M |
| Foreign Exchange rate Adjustments | 593.00K | -111.00K | 22.00K | 52.00K | -101.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.43M | 3.05M | 6.18M | 1.11M | -481.00K |